|
Volumn 7, Issue SUPPL. 2, 2000, Pages 295-298
|
Human immunodeficiency virus: State of the art in maternity units;Virus de l'immunodeficience humaine: Actualites en maternite
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIRETROVIRUS AGENT;
COTRIMOXAZOLE;
EFAVIRENZ;
LAMIVUDINE;
NEVIRAPINE;
ZALCITABINE;
ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CESAREAN SECTION;
CONFERENCE PAPER;
FIRST TRIMESTER PREGNANCY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MATERNITY WARD;
MEMBRANE RUPTURE;
NEWBORN;
NEWBORN INFECTION;
PNEUMOCYSTIS CARINII PNEUMONIA;
RISK FACTOR;
SECOND TRIMESTER PREGNANCY;
THIRD TRIMESTER PREGNANCY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VERTICAL TRANSMISSION;
ARTICLE;
DISEASE TRANSMISSION;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
PREGNANCY;
PREGNANCY COMPLICATION;
VIROLOGY;
ANTI-HIV AGENTS;
CESAREAN SECTION;
DISEASE TRANSMISSION, VERTICAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HIV-2;
HUMANS;
INFANT, NEWBORN;
LAMIVUDINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
ZIDOVUDINE;
|
EID: 0033820141
PISSN: 0929693X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (8)
|